Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639
KEY BENEFITS:
- Morpheus8 is the first and only FDA cleared fractional radiofrequency device for soft tissue contraction.
- Equipped with SCALE and BURST functionalities that automatically deploy bipolar RF to multi-level treatment depths and programmable energy levels with a single pulse.
- A versatile tool to safely and efficaciously meet patient demand for dermal contraction and subdermal adipose treatments.
- Four interchangeable fractional tips with different microneedling configurations:
• 12 pin Morpheus8 Burst Prime
• 24 pin Morpheus8 Burst
• 24 pin Morpheus8 Burst Resurfacing
• 40 pin Morpheus8 Burst Deep
MORPHEUS8 BURST
Morpheus8 Burst is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. Equipped with proprietary Burst and Scale functionalities, Morpheus8 Burst has the unique ability, in a single pulse, to automatically deploy bipolar RF to multi-level soft tissue depths, contracting both adipose tissue and dermal tissue.
MORPHEUS8 BURST DEEP
Morpheus8 Burst Deep is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. With the ability to deliver both subdermal multi-level contraction and dermal contraction, Morpheus8 Burst Deep provides the deepest levels of targeted RF energy deposition available. Equipped with proprietary Burst and Scale technologies, Morpheus8 Burst Deep’s large 40-pin surface tip automatically deploys bipolar RF energy, in millisecond intervals, to multi-level treatment depths and energy levels in a single pulse.
Morpheus8 Burst Videos
Approved intended use varies by country; please check with local providers or representatives. Individual treatment results may vary.
Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.
Get in touch
KEY BENEFITS:
- Morpheus8 is the first and only FDA cleared fractional radiofrequency device for soft tissue contraction.
- Equipped with SCALE and BURST functionalities that automatically deploy bipolar RF to multi-level treatment depths and programmable energy levels with a single pulse.
- A versatile tool to safely and efficaciously meet patient demand for dermal contraction and subdermal adipose treatments.
- Four interchangeable fractional tips with different microneedling configurations:
• 12 pin Morpheus8 Burst Prime
• 24 pin Morpheus8 Burst
• 24 pin Morpheus8 Burst Resurfacing
• 40 pin Morpheus8 Burst Deep
MORPHEUS8 BURST
Morpheus8 Burst is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. Equipped with proprietary Burst and Scale functionalities, Morpheus8 Burst has the unique ability, in a single pulse, to automatically deploy bipolar RF to multi-level soft tissue depths, contracting both adipose tissue and dermal tissue.
MORPHEUS8 BURST DEEP
Morpheus8 Burst Deep is a fractional radiofrequency (FRF) technology intended for dermatological applications that require contraction/coagulation of soft tissue or hemostasis. With the ability to deliver both subdermal multi-level contraction and dermal contraction, Morpheus8 Burst Deep provides the deepest levels of targeted RF energy deposition available. Equipped with proprietary Burst and Scale technologies, Morpheus8 Burst Deep’s large 40-pin surface tip automatically deploys bipolar RF energy, in millisecond intervals, to multi-level treatment depths and energy levels in a single pulse.
Morpheus8 Video
Approved intended use varies by country; please check with local providers or representatives. Individual treatment results may vary.
Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.